Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Transient Oral Human Cytomegalovirus Infections Indicate Inefficient Viral Spread from Very Few Initially Infected Cells.

Mayer BT, Krantz EM, Swan D, Ferrenberg J, Simmons K, Selke S, Huang ML, Casper C, Corey L, Wald A, Schiffer JT, Gantt S.

J Virol. 2017 May 26;91(12). pii: e00380-17. doi: 10.1128/JVI.00380-17. Print 2017 Jun 15.

PMID:
28381570
2.

Recent Insights into the HIV/AIDS Pandemic.

Becerra JC, Bildstein LS, Gach JS.

Microb Cell. 2016 Sep 5;3(9):451-475. doi: 10.15698/mic2016.09.529. Review.

3.

Randomized Cross-Sectional Study to Compare HIV-1 Specific Antibody and Cytokine Concentrations in Female Genital Secretions Obtained by Menstrual Cup and Cervicovaginal Lavage.

Archary D, Liebenberg LJ, Werner L, Tulsi S, Majola N, Naicker N, Dlamini S, Hope TJ, Samsunder N, Abdool Karim SS, Morris L, Passmore JA, Garrett NJ.

PLoS One. 2015 Jul 6;10(7):e0131906. doi: 10.1371/journal.pone.0131906. eCollection 2015.

4.

Antiretroviral Pre-Exposure Prophylaxis Does Not Enhance Immune Responses to HIV in Exposed but Uninfected Persons.

Pattacini L, Murnane PM, Baeten JM, Fluharty TR, Thomas KK, Bukusi E, Katabira E, Mugo N, Donnell D, Lingappa JR, Celum C, Marzinke M, McElrath MJ, Lund JM; Partners PrEP Study Team.

J Infect Dis. 2015 Jun 15;211(12):1943-52. doi: 10.1093/infdis/jiu815. Epub 2014 Dec 17.

5.

Innate activation of MDC and NK cells in high-risk HIV-1-exposed seronegative IV-drug users who share needles when compared with low-risk nonsharing IV-drug user controls.

Tomescu C, Seaton KE, Smith P, Taylor M, Tomaras GD, Metzger DS, Montaner LJ.

J Acquir Immune Defic Syndr. 2015 Mar 1;68(3):264-73. doi: 10.1097/QAI.0000000000000470.

6.

HIV-1 specific IgA detected in vaginal secretions of HIV uninfected women participating in a microbicide trial in Southern Africa are primarily directed toward gp120 and gp140 specificities.

Seaton KE, Ballweber L, Lan A, Donathan M, Hughes S, Vojtech L, Moody MA, Liao HX, Haynes BF, Galloway CG, Richardson BA, Karim SA, Dezzutti CS, McElrath MJ, Tomaras GD, Hladik F.

PLoS One. 2014 Jul 23;9(7):e101863. doi: 10.1371/journal.pone.0101863. eCollection 2014.

7.

Differential regulatory T cell activity in HIV type 1-exposed seronegative individuals.

Pattacini L, Murnane PM, Kahle EM, Bolton MJ, Delrow JJ, Lingappa JR, Katabira E, Donnell D, McElrath MJ, Baeten JM, Lund JM.

AIDS Res Hum Retroviruses. 2013 Oct;29(10):1321-9. doi: 10.1089/AID.2013.0075. Epub 2013 Jul 30.

8.

Superior control of HIV-1 replication by CD8+ T cells targeting conserved epitopes: implications for HIV vaccine design.

Kunwar P, Hawkins N, Dinges WL, Liu Y, Gabriel EE, Swan DA, Stevens CE, Maenza J, Collier AC, Mullins JI, Hertz T, Yu X, Horton H.

PLoS One. 2013 May 31;8(5):e64405. doi: 10.1371/journal.pone.0064405. Print 2013.

9.

HIV-1-specific enzyme-linked immunosorbent spot assay responses in HIV-1-exposed uninfected partners in discordant relationships compared to those in low-risk controls.

Guthrie BL, Lohman-Payne B, Liu AY, Bosire R, Nuvor SV, Choi RY, Mackelprang RD, Kiarie JN, De Rosa SC, Richardson BA, John-Stewart GC, Farquhar C.

Clin Vaccine Immunol. 2012 Nov;19(11):1798-805. doi: 10.1128/CVI.00179-12. Epub 2012 Sep 12.

10.

A genetic polymorphism of FREM1 is associated with resistance against HIV infection in the Pumwani sex worker cohort.

Luo M, Sainsbury J, Tuff J, Lacap PA, Yuan XY, Hirbod T, Kimani J, Wachihi C, Ramdahin S, Bielawny T, Embree J, Broliden K, Ball TB, Plummer FA.

J Virol. 2012 Nov;86(21):11899-905. doi: 10.1128/JVI.01499-12. Epub 2012 Aug 22.

11.

For protection from HIV-1 infection, more might not be better: a systematic analysis of HIV Gag epitopes of two alleles associated with different outcomes of HIV-1 infection.

Luo M, Daniuk CA, Diallo TO, Capina RE, Kimani J, Wachihi C, Kimani M, Bielawny T, Peterson T, Mendoza MG, Kiazyk S, Ball TB, Plummer FA.

J Virol. 2012 Jan;86(2):1166-80. doi: 10.1128/JVI.05721-11. Epub 2011 Nov 9.

12.

Risk factors and immune response to hepatitis E viral infection among acute hepatitis patients in Assiut, Egypt.

Eldin SS, Seddik I, Daef EA, Shata MT, Raafat M, Abdel Baky L, Nafeh MA.

Egypt J Immunol. 2010;17(1):73-86.

13.

Evidence for the innate immune response as a correlate of protection in human immunodeficiency virus (HIV)-1 highly exposed seronegative subjects (HESN).

Tomescu C, Abdulhaqq S, Montaner LJ.

Clin Exp Immunol. 2011 May;164(2):158-69. doi: 10.1111/j.1365-2249.2011.04379.x. Epub 2011 Mar 17. Review.

14.

Lack of detectable HIV-1-specific CD8(+) T cell responses in Zambian HIV-1-exposed seronegative partners of HIV-1-positive individuals.

Addo MM, Altfeld M, Brainard DM, Rathod A, Piechocka-Trocha A, Fideli U, Mulenga J, Shutes E, Alvino DM, Hunter E, Allen SA, Walker BD.

J Infect Dis. 2011 Jan 15;203(2):258-62. doi: 10.1093/infdis/jiq028. Epub 2010 Dec 9.

15.

Differences in HIV-specific T cell responses between HIV-exposed and -unexposed HIV-seronegative individuals.

Ritchie AJ, Campion SL, Kopycinski J, Moodie Z, Wang ZM, Pandya K, Moore S, Liu MK, Brackenridge S, Kuldanek K, Legg K, Cohen MS, Delwart EL, Haynes BF, Fidler S, McMichael AJ, Goonetilleke N.

J Virol. 2011 Apr;85(7):3507-16. doi: 10.1128/JVI.02444-10. Epub 2011 Jan 26.

16.

Strong hepatitis C virus (HCV)-specific cell-mediated immune responses in the absence of viremia or antibodies among uninfected siblings of HCV chronically infected children.

Hashem M, El-Karaksy H, Shata MT, Sobhy M, Helmy H, El-Naghi S, Galal G, Ali ZZ, Esmat G, Abdelwahab SF, Strickland GT, El-Kamary SS.

J Infect Dis. 2011 Mar 15;203(6):854-61. doi: 10.1093/infdis/jiq123. Epub 2011 Jan 21.

17.

Epigenetic control of IRF1 responses in HIV-exposed seronegative versus HIV-susceptible individuals.

Su RC, Sivro A, Kimani J, Jaoko W, Plummer FA, Ball TB.

Blood. 2011 Mar 3;117(9):2649-57. doi: 10.1182/blood-2010-10-312462. Epub 2011 Jan 3.

18.

What does the structure-function relationship of the HIV-1 Tat protein teach us about developing an AIDS vaccine?

Campbell GR, Loret EP.

Retrovirology. 2009 May 25;6:50. doi: 10.1186/1742-4690-6-50. Review.

19.

Impaired viral entry cannot explain reduced CD4+ T cell susceptibility to HIV type 1 in certain highly exposed individuals.

Speelmon EC, Livingston-Rosanoff D, Desbien AL, Lee J, Wick WD, Hladik F, McElrath MJ.

AIDS Res Hum Retroviruses. 2008 Nov;24(11):1415-27. doi: 10.1089/aid.2007.0256.

20.

Immunity to HIV-1 is influenced by continued natural exposure to exogenous virus.

Willberg CB, McConnell JJ, Eriksson EM, Bragg LA, York VA, Liegler TJ, Hecht FM, Grant RM, Nixon DF.

PLoS Pathog. 2008 Oct;4(10):e1000185. doi: 10.1371/journal.ppat.1000185. Epub 2008 Oct 24.

Supplemental Content

Support Center